Myriad Genetics Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
778,216.00
723,100.00
753,800.00
769,900.00
772,600.00
Cost of Goods Sold (COGS) incl. D&A
109,201.00
147,400.00
157,300.00
171,200.00
177,200.00
Gross Income
669,015.00
575,700.00
596,500.00
598,700.00
595,400.00
SG&A Expense
394,573.00
441,500.00
429,700.00
550,800.00
537,900.00
EBIT
274,442.00
134,200.00
166,800.00
-
57,500.00
Unusual Expense
-
-
-
2,900.00
61,200.00
Non Operating Income/Expense
1,974.00
300.00
1,200.00
700.00
400.00
Interest Expense
-
-
-
6,000.00
3,200.00
Pretax Income
277,865.00
134,900.00
168,900.00
40,900.00
116,900.00
Income Tax
101,640.00
54,700.00
43,600.00
20,600.00
14,000.00
Consolidated Net Income
176,225.00
80,200.00
125,300.00
20,300.00
130,900.00
Net Income
176,225.00
80,200.00
125,300.00
20,500.00
131,100.00
Net Income After Extraordinaries
176,225.00
80,200.00
125,300.00
20,500.00
131,100.00
Net Income Available to Common
176,225.00
80,200.00
125,300.00
20,500.00
131,100.00
EPS (Basic)
2.25
1.08
1.71
0.30
1.82
Basic Shares Outstanding
75,728.00
71,300.00
70,000.00
68,300.00
69,400.00
EPS (Diluted)
2.25
1.08
1.71
0.30
1.82
Diluted Shares Outstanding
78,182.00
74,500.00
73,400.00
68,800.00
72,000.00
EBITDA
288,261.00
159,200.00
193,500.00
96,200.00
111,900.00
Non-Operating Interest Income
5,397.00
400.00
900.00
1,200.00
1,800.00
Minority Interest Expense
-
-
-
200.00
200.00
About Myriad Genetics
View Profile
